Long-Term Aspirin Use Reduces Colorectal Cancer Risk – Nurses’ Health Study
This article was originally published in The Tan Sheet
Executive Summary
Women who took more than 14 aspirin per week for 10 years or more demonstrated a 33% lower risk for colorectal cancer compared to nonusers, according to a study published in the Aug. 24-31 Journal of the American Medical Association
You may also be interested in...
Aspirin, NSAID Risks Outweigh Colon Cancer Benefits – AHRQ Task Force
A panel of prevention and primary care experts sponsored by the Agency for Healthcare Research and Quality is recommending against the use of aspirin and non-steroidal anti-inflammatory drugs for primary prevention of colorectal cancer
Aspirin, NSAID Risks Outweigh Colon Cancer Benefits – AHRQ Task Force
A panel of prevention and primary care experts sponsored by the Agency for Healthcare Research and Quality is recommending against the use of aspirin and non-steroidal anti-inflammatory drugs for primary prevention of colorectal cancer
Aspirin, NSAID Risks Outweigh Colon Cancer Benefits – AHRQ Task Force
A panel of prevention and primary care experts sponsored by the Agency for Healthcare Research and Quality is recommending against the use of aspirin and non-steroidal anti-inflammatory drugs for primary prevention of colorectal cancer